Methods, systems, and devices for imaging microscopic tumors

US9820653B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9820653-B2
Application numberUS-201615074614-A
CountryUS
Kind codeB2
Filing dateMar 18, 2016
Priority dateSep 20, 2013
Publication dateNov 21, 2017
Grant dateNov 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An imager for in vivo viewing of diseased tissue by way of fluorescently conjugated molecules. A generally planar imaging surface with a microlens array. The imager may be modular, such that a plurality of generally planar imaging surfaces can be used to image various aspects of disease tissue simultaneously. Certain implementations include an angle-selective imager, wherein light from substantially perpendicular to the plane of the imager is received, while incident light is selectively eliminated.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for imaging biological material in a patient, comprising: a. a fluorescently conjugated molecule capable of binding to the biological material; b. a light source; c. a fiber optic light guide; d. an elongate probe sized for placement inside the cavity of the patient, further comprising at least one substantially planar detection surface, the detection surface further comprising: i. an imager; ii. a waveguide in luminary communication with the light source; and iii. an optical filter; and e. a visualization system in electrical communication with the probe; wherein the waveguide is capable of emitting light toward the biological material, such that the biological material's emitted fluorescence is received by the imager for display by way of the visualization system. 2. The system of claim 1 , further comprising a microlens array. 3. The system of claim 1 , wherein the imager further comprises at least one photodiode. 4. The system of claim 3 , further comprising a complementary metal oxide semiconductor process. 5. The system of claim 1 , further comprising a charge-coupled device process. 6. The system of claim 2 , further comprising a waveguide stencil configured to eliminate oblique light from reaching the microlens array. 7. The system of claim 1 , wherein the fluorescently conjugated molecule binds biological material selected from the group consisting of: breast cancer cells, prostate cancer cells, cancer cells inside a tumor bed, cancer cells surrounding a tumor bed, disease cells in the microenvironment surrounding a tumor bed. 8. The system of claim 1 , wherein optical filter is directly patterned on the imager surface. 9. The system of claim 1 , wherein the waveguide further comprises a plurality of optical gratings. 10. The system of claim 1 , further comprising a surgical tool, wherein the elongate probe is operationally coupled with the surgical tool. 11. An angle selective imager, comprising: a) a light source further comprising a light guide; b) an elongate probe sized to be positioned within a body cavity of a patient undergoing surgery, wherein the device is operationally coupled with the light source by way of the light guide, said device further comprising at least one substantially planar detection surface, the detection surface further comprising: i. an imager further comprising a plurality of pixels; and ii. a microlens array; and c) a visualization system in electrical communication with the probe capable of computing and displaying fluorescence wherein the detection surface is adapted to allow light from substantially perpendicular angles from surface to pass through the microlens to the imager, and exclude light incident form other directions. 12. The imager of claim 11 , further comprising a micro-grating. 13. The imager of claim 11 , further comprising a nano-grating. 14. The imager of claim 13 , further comprising at least one cylinder disposed adjacent to the microlens array adjacent to an imager pixel. 15. The imager of claim 14 , further comprising a waveguide, wherein the waveguide is in luminary communication with the light guide. 16. The imager of claim 15 , further comprising an optical filter, wherein the waveguide is capable of emitting light toward fluorescently-tagged cells such that emitted fluorescence is passed through the microlens array and nano-grating and received by the imager. 17. A modular system for imaging fluorescently tagged disease cells, comprising: a. at least one imager further comprising a plurality of pixels; b. at least one waveguide further comprising at least one remote light source, wherein the at least one remote light source is capable of emitting light through the at least one waveguide to fluoresce the tagged cells; c. at least one microlens array configured to direct light to the imager pixels; wherein the at least one microlens array, imager and waveguide are disposed in a substantially parallel and planar fashion facing the tagged cells so as to transmit light substantially perpendicularly from the tagged cells to the imager by way of the microlens array. 18. The modular system of claim 17 , comprising an optical filter. 19. The modular system of claim 18 , further comprising an additional modular system disposed to face an alternative plane of tagged disease cells. 20. The modular system of claim 18 , wherein the modular system further comprising an angle sensitivity grating.

Assignees

Inventors

Classifications

  • quantum dots, fluorescent nanocrystals · CPC title

  • Methine dyes, e.g. cyanine dyes · CPC title

  • Antibodies · CPC title

  • for introduction into the body, e.g. by catheters (A61B5/1459 takes precedence) · CPC title

  • A61B5/0071Primary

    by measuring fluorescence emission · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9820653B2 cover?
An imager for in vivo viewing of diseased tissue by way of fluorescently conjugated molecules. A generally planar imaging surface with a microlens array. The imager may be modular, such that a plurality of generally planar imaging surfaces can be used to image various aspects of disease tissue simultaneously. Certain implementations include an angle-selective imager, wherein light from substant…
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification A61B5/0071. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).